Executive Summary: Electronic health record (EHR) and health IT software companies are valued differently from traditional service businesses because a meaningful share of their worth comes from recurring revenue quality, retention, and the difficulty customers face when switching systems. Buyers and investors typically focus on annual recurring revenue (ARR), net revenue retention (NRR), implementation stickiness, […]
Executive Summary. Valuing an AI-powered diagnostics company requires more than applying a standard revenue multiple. Buyers and investors focus on the durability of FDA clearance, the quality of clinical validation, the structure of licensing or software revenue, and the company’s ability to scale inside health systems. Companies with credible regulatory traction, recurring revenue, strong gross […]
Executive Summary: Revenue cycle management (RCM) software companies are valued not only on current earnings, but on the quality, durability, and predictability of the revenue they generate. For Chicago business owners, investors, and advisors, the most important valuation drivers typically include revenue per provider, claim success rates, net revenue retention (NRR), customer concentration, and the […]
Telehealth platform valuation depends on more than reported revenue. Buyers and investors look closely at patient visit volume, revenue per visit, payer contract penetration, retention, and whether growth remains durable as post-pandemic demand normalizes. For Chicago business owners, especially those serving regional health systems, employer groups, or specialty practices, understanding how these metrics affect value […]
Healthtech business valuation focuses on how digital health companies create durable revenue, manage clinical and regulatory risk, and turn usage data into measurable economics. For Chicago business owners, investors, and advisors, understanding how valuer teams price these companies is essential because traditional EBITDA analysis often understates the value of fast-growing platforms with recurring subscription revenue, […]
Executive Summary: InsurTech valuations are driven less by headline revenue alone and more by the quality of that revenue, the durability of customer retention, and the economics of insurance underwriting. For Chicago business owners, investors, and advisors evaluating an InsurTech company, key metrics such as loss ratio, combined ratio, premium growth, and retention rates help […]
Executive Summary: Buy-now-pay-later (BNPL) businesses were once valued largely on growth, active users, and payment volume. That approach has changed. Today, buyers and investors place far more weight on the metrics that reveal whether a BNPL platform can convert gross merchandise value (GMV) into durable earnings, including merchant fee rate, default rate, contribution margin, and […]
Executive Summary: Neobank valuation is driven by a different set of metrics than those used for traditional banks. Investors rarely rely on book value alone. Instead, they focus on deposits per user, customer acquisition cost (CAC), revenue per account, churn, net revenue retention, and the neobank’s path to profitability. For Chicago business owners, understanding these […]
Executive Summary: Valuing a payment processing company requires more than applying a generic revenue or EBITDA multiple. Buyers and investors focus on the quality of payment volume, the economics of each transaction, the durability of customer relationships, and the scalability of the platform. The most important drivers are total payment volume (TPV), take rate, gross […]
Executive Summary: Fintech companies are valued differently from traditional banks, lenders, and software businesses because their economics sit at the intersection of financial services and technology. Investors and buyers typically look at recurring revenue quality, growth consistency, regulatory risk, unit economics, and capital efficiency before applying revenue multiples, EBITDA multiples, or a discounted cash flow […]
- 1
- 2